Albert Labs provides Corporate Update

/CNW/ - Albert Labs International Corp. (Albert Labs (CSE: ABRT) (FSE: VB50), the "Company"), a pharmaceutical drug development company focussed on gaining...

Related Keywords

United States ,Portugal ,Porto ,Canada ,United Kingdom ,Manchester ,Vancouver ,British Columbia ,America ,Canadian ,British ,Katie Shelton Innes ,Michael Raymont ,Sara Tai ,Access Programme ,National Cancer Research Institute ,University Of Manchester ,Albert Labs International Corp ,Good Laboratory Practice ,Albert Lab ,Health Canada Licence ,Business Of Albert Labs International Corp ,Association For The British Pharmaceutical Industry ,European Union ,Canadian Securities Exchange ,Labs International ,Albert Labs ,Private Placement ,Chrystal Capital ,Real World Evidence ,Pre Clinical Advisory Board ,Special Access Programme ,Christie Hospital ,Lead Clinical Researcher ,Senior Clinical Psychology Professor ,British Pharmaceutical Industry ,Senior Vice President ,Commercial Strategy ,Special Access Programmes ,Good Manufacturing Practice ,Clinical Trial Application ,Investigational New Drug ,Albert Labs International ,Executive Officer ,